Unit (free text)
Nicotinell Mint 2mg Lozenge contains 2mg Nicotine (as Nicotine Bitartrate Dihydrate), Also contains Maltitol (E965), Aspartame (E951) and Sodium (9.8mg per lozenge), See leaflet for further information
For allergens, see ingredients in bold
GlaxoSmithKline (UK) Trading Limited
GlaxoSmithKline (UK) Trading Limited, Brentford, TW8 9GS, U.K.
Preparation and Usage
You are more likely to quit smoking when using this product with help from your pharmacist, doctor, a trained counsellor, or a support programme
If you need advice before starting to use nicotine lozenges, talk to your doctor, nurse or pharmacist.
Instructions for use
For adults over 18 years of age
Read the enclosed instructions carefully before use.
You must not smoke whilst using these lozenges.
For oromucosal use. Suck 1 lozenge when you feel the urge to smoke, but initially try to use no more than 1 lozenge every 1-2 hours.
Most people use 8-12 lozenges per day.
This product is designed to be sucked slowly, do not swallow or chew. These lozenges should not be sucked like ordinary lozenges. Read the Nicotinell sucking technique in the enclosed leaflet carefully before use.
Only use 1 lozenge at a time and do not use more than 15 of the 2mg lozenges a day.
Do not store above 25°C.
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
Warnings and precautions for use
Do not use if you:
Are a non-smoker
Are allergic (hypersensitive) to any of the ingredients
Consult your doctor, nurse or pharmacist before starting to use these lozenges if you:
Are under 18 years of age
Have any serious heart disease
Are pregnant or breast-feeding
Are under a doctor’s care or taking prescribed medication
Do not exceed the stated dose
Keep all medicines out of the reach and sight of children.
As we are always looking to improve our products, our formulations change from time to time, so please always check the product packaging before use.
Regulated Product Name
Mint 2mg Compressed Lozenge Extra Strength
Brentford, TW8 9GS, U.K.
Trade marks are owned by or licensed to the GSK group of companies.